Remove 2029 Remove Drug Development Remove Marketing Remove Vaccine
article thumbnail

Thirteen potential blockbuster drugs to watch in 2024

Drug Discovery World

Thirteen new-to-market therapeutics and drugs poised to launch in 2024 will achieve ‘blockbuster’ status by 2029 or deliver game-changing benefits to patients. The first approvals of RSV vaccines (RSVpreF and RSVpreF3) targeted at infants and older adults mark a significant public health milestone.

Drugs 173
article thumbnail

What is the largest CRO in the US?

Vial

By geographical region, the global CRO services market in 2023 was dominated by North America. Growth factors for this market included the growing size of the pharmaceutical industry, the increasing number of clinical trials , substantial funds dedicated to pharma and biotech R&D, and the growing biosimilars and generics market.

article thumbnail

Fewer New Drugs but Affordable Access for Existing Ones: The Big Elephant in the Room

Policy Prescription

Within the context of the global pandemic and a coming battle in Congress about the high cost of prescription drugs, Patients for Affordable Drugs founder David Mitchell tactfully presents the roadmap of Covid vaccine development to prevent people from buying into Big Pharma’s scare tactic. 3) were implemented.

Drugs 52